---
title: "Stopping smoking increases depression and anxiety  -  Vitamin D appears to help"
slug: "stopping-smoking-increases-depression-and-anxiety-vitamin-d-appears-to-help"
aliases:
  - "/Stopping+smoking+increases+depression+and+anxiety+-+Vitamin+D+appears+to+help"
  - "/15930"
tiki_page_id: 15930
date: 2025-04-11
---


{{< toc >}}

---

### The Role of Vitamin D3 in Alleviating Anxiety and Depression During Nicotine Withdrawal

 **[Perplexity AI - Deep Research April 2025](https://www.perplexity.ai/search/do-3-hours-of-screen-time-dail-wcnSkHdaSquT2OjKIIoO.g)** 

Recent scientific evidence suggests that vitamin D3 supplementation may have significant potential in reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. This report examines the existing research on this relationship, exploring both the neurobiological mechanisms and clinical implications of vitamin D3 as a potential adjunctive therapy for individuals attempting to quit smoking.

#### Understanding Nicotine Withdrawal and Its Neurobiological Basis

Nicotine withdrawal represents a significant challenge for individuals attempting to quit smoking, with symptoms typically beginning within 30 minutes of the last cigarette and peaking within the first three to seven days. These symptoms can persist for weeks or even months, significantly increasing the risk of relapse <sup>[4]</sup> <sup>[6]</sup>. Common nicotine withdrawal symptoms include intense cravings, anxiety, irritability, depressed mood, difficulty concentrating, insomnia, and restlessness <sup>[4]</sup> <sup>[6]</sup>. 

The neurobiological underpinnings of nicotine withdrawal-induced anxiety and depression are complex and involve multiple neurotransmitter systems. One critical mechanism appears to involve the N-Methyl-D-aspartate (NMDA) receptor, a glutamate receptor that plays a significant role in synaptic plasticity, learning, and memory. During nicotine withdrawal, NMDA receptors become overexpressed, particularly the NR2A subunit, which correlates with increased anxiety-like behaviors <sup>[1]</sup> <sup>[2]</sup>.

##### The NMDA Receptor-Anxiety Connection

Research indicates that NMDA receptor overactivation promotes anxiety and depression through two primary mechanisms:

* 1. Decreased protein synthesis through downregulation of the BDNF-PI3K-Akt-mTOR pathway, which impedes maintenance of synapses and growth of new neurons and synapses (processes critical for emotional regulation) <sup>[2]</sup>.

* 2. Excessive NMDA activation leading to decreased sensitivity to dopamine in the striatum, a brain region responsible for motivation, reward, and pleasure <sup>[2]</sup>. This diminished dopaminergic function is associated with both depression and addiction-related withdrawal symptoms.

#### Evidence for Vitamin D3's Effects on Nicotine Withdrawal

##### Animal Studies Demonstrating Efficacy

Recent research has produced compelling evidence that vitamin D3 supplementation may significantly reduce anxiety and depressive-like behaviors induced by nicotine withdrawal. A 2021 study with male C57/BL6 mice demonstrated that dietary supplementation with vitamin D3 (10,000 U/Kg) for six weeks ameliorated anxiety-like behaviors during nicotine withdrawal <sup>[1]</sup>. Specifically, vitamin D3-treated mice showed:

* 1. Increased duration spent in the central zone during open field tests

* 2. Decreased numbers of buried marbles in marble-burying tests

* 3. Increased exploratory behavior and overall locomotor activity

These behavioral improvements indicate reduced anxiety levels during the nicotine withdrawal period in the supplemented group compared to controls <sup>[1]</sup>.

More recently, a 2025 study with male Wistar rats further confirmed these findings, showing that vitamin D3 administration effectively prevented both anxiety and depression induced by nicotine withdrawal <sup>[5]</sup>. This study tested various dosages (100, 1000, and 10,000 IU/kg) and found effective results, suggesting a dose-dependent response may exist <sup>[5]</sup>.

#### Mechanisms of Vitamin D3's Anti-Anxiety Effects During Nicotine Withdrawal

##### Modulation of NMDA Receptor Expression

The most well-documented mechanism by which vitamin D3 appears to reduce withdrawal-related anxiety is through downregulation of hippocampal NR2A expression. The 2021 study demonstrated that vitamin D3 supplementation significantly attenuated both protein and mRNA levels of NR2A in the hippocampus of nicotine-withdrawn mice <sup>[1]</sup>. This suggests that vitamin D3 may directly counteract the pathological overexpression of NMDA receptors that occurs during nicotine withdrawal.

##### Anti-inflammatory Effects

Vitamin D3 also appears to exert anti-inflammatory effects that may contribute to its anti-anxiety properties. Research on methadone maintenance treatment, while not specifically addressing nicotine withdrawal, showed that vitamin D supplementation (50,000 IU every two weeks) downregulated interleukin-1 (IL-1) expression in peripheral blood mononuclear cells <sup>[3]</sup>. Inflammation has been increasingly linked to both anxiety and depression, suggesting another pathway by which vitamin D3 might improve withdrawal symptoms.

##### Impact on Oxidative Stress and Serotonergic Transmission

The 2025 study further expanded our understanding of vitamin D3's mechanisms by suggesting its effects may also involve modulation of oxidative stress and serotonergic transmission <sup>[5]</sup>. While the specifics of these mechanisms require further investigation, this multi-system approach suggests vitamin D3 may address nicotine withdrawal symptoms through several complementary pathways.

#### Limitations of Current Evidence and Future Research Directions

While the evidence supporting vitamin D3's role in reducing nicotine withdrawal-induced anxiety and depression is promising, several important limitations must be acknowledged:

##### Animal vs. Human Studies

The most compelling evidence thus far comes from rodent models, with limited direct evidence in human subjects. The study on methadone maintenance treatment patients found that vitamin D supplementation did not significantly change clinical opiate withdrawal symptoms, suggesting potential differences between opiate and nicotine withdrawal or between animal and human responses <sup>[3]</sup>.

##### Optimal Dosing and Duration (in rats and humans)

Questions remain regarding optimal dosing, timing, and duration of vitamin D3 supplementation for nicotine withdrawal. Studies have used various dosages, from 100 IU/kg to 10,000 IU/kg in animals <sup>[1]</sup> <sup>[5]</sup>, and 50,000 IU every two weeks in humans <sup>[3]</sup>, without clear consensus on the ideal therapeutic approach.

##### Individual Variability

Baseline vitamin D status likely influences treatment response, but most studies have not stratified results based on pre-existing vitamin D levels. Given the high prevalence of vitamin D deficiency in many populations, including smokers, this represents an important variable for future research.

#### Clinical Implications and Practical Applications

Despite these limitations, the existing evidence suggests several potential clinical applications:

##### Adjunctive Therapy for Smoking Cessation

Vitamin D3 supplementation could potentially serve as a safe, accessible adjunctive therapy alongside existing smoking cessation approaches. Given the relatively benign side effect profile of appropriate vitamin D supplementation, it represents a low-risk intervention that might enhance quit rates by reducing withdrawal-related anxiety and depression.

##### Targeted Approach for Vulnerable Populations

The anxiety and depression associated with nicotine withdrawal may be particularly challenging for individuals with pre-existing mental health conditions. For these vulnerable populations, vitamin D3 supplementation might offer specific benefits, though targeted studies are needed.

##### Integration with Existing Approaches

Rather than a standalone treatment, vitamin D3 supplementation could complement existing strategies, including behavioral therapy, nicotine replacement therapy, and other pharmacological interventions. The potential synergistic effects of combining these approaches warrant further investigation.

#### Conclusion

The current evidence suggests that vitamin D3 supplementation shows promise for reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. The primary mechanism appears to involve downregulation of NR2A expression in the hippocampus, counteracting the pathological NMDA receptor overactivation that occurs during withdrawal. Additional benefits may stem from vitamin D3's anti-inflammatory properties and effects on oxidative stress and serotonergic transmission.

While more research is needed, particularly human clinical trials with standardized dosing protocols and attention to baseline vitamin D status, the existing evidence provides a compelling rationale for further investigation of vitamin D3 as a supportive intervention for individuals navigating the challenging process of nicotine withdrawal. For those attempting to quit smoking, especially individuals prone to anxiety or depression, vitamin D3 supplementation may represent a valuable addition to their cessation toolkit.

##### Citations:

<sup>[1]</sup> https://pmc.ncbi.nlm.nih.gov/articles/PMC8200643/

<sup>[2]</sup> https://www.reddit.com/r/Nootropics/comments/pqpww1/vitamin_d3_reduces_hippocampal_nmdanr2a_and/

<sup>[3]</sup> https://brieflands.com/articles/ijpbs-86969

<sup>[4]</sup> https://www.verywellmind.com/what-to-expect-from-nicotine-withdrawal-22467

<sup>[5]</sup> https://www.tandfonline.com/doi/full/10.1080/13813455.2025.2483508  (Rats: April 2025 $$$ paywall)

<sup>[6]</sup> https://www.healthline.com/health/smoking/nicotine-withdrawal

<sup>[7]</sup> https://www.sciencedirect.com/science/article/abs/pii/S0006295223004239

<sup>[8]</sup> https://www.sciencedirect.com/science/article/pii/S277239252400049X

<sup>[9]</sup> https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805442

<sup>[10]</sup> https://www.optimallivingdynamics.com/blog/9-nutrients-proven-to-help-you-overcome-addiction-and-withdrawal-nutrition-recovery-vitamins-minerals-amino-acid-symptoms-supplements-diet-substance-drug-abuse-syndrome-cravings-opiate-alcoholism-food

<sup>[11]</sup> https://pubmed.ncbi.nlm.nih.gov/40198132/

<sup>[12]</sup> https://www.physio-pedia.com/Vitamin_D_and_the_Effect_on_Mental_Health

<sup>[13]</sup> https://www.sciencedirect.com/science/article/pii/S2772392525000057

<sup>[14]</sup> https://reactionrecovery.com/nicotine/


<pre style="background-color: #e0e0e0; white-space: pre-wrap;">
<code class="language-text">
Markdown:
--------
{{&lt; toc &gt;}}

---

### The Role of Vitamin D3 in Alleviating Anxiety and Depression During Nicotine Withdrawal

 **[Perplexity AI - Deep Research April 2025](https://www.perplexity.ai/search/do-3-hours-of-screen-time-dail-wcnSkHdaSquT2OjKIIoO.g)** 

Recent scientific evidence suggests that vitamin D3 supplementation may have significant potential in reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. This report examines the existing research on this relationship, exploring both the neurobiological mechanisms and clinical implications of vitamin D3 as a potential adjunctive therapy for individuals attempting to quit smoking.

#### Understanding Nicotine Withdrawal and Its Neurobiological Basis

Nicotine withdrawal represents a significant challenge for individuals attempting to quit smoking, with symptoms typically beginning within 30 minutes of the last cigarette and peaking within the first three to seven days. These symptoms can persist for weeks or even months, significantly increasing the risk of relapse &lt;sup&gt;[4]&lt;/sup&gt; &lt;sup&gt;[6]&lt;/sup&gt;. Common nicotine withdrawal symptoms include intense cravings, anxiety, irritability, depressed mood, difficulty concentrating, insomnia, and restlessness &lt;sup&gt;[4]&lt;/sup&gt; &lt;sup&gt;[6]&lt;/sup&gt;. 

The neurobiological underpinnings of nicotine withdrawal-induced anxiety and depression are complex and involve multiple neurotransmitter systems. One critical mechanism appears to involve the N-Methyl-D-aspartate (NMDA) receptor, a glutamate receptor that plays a significant role in synaptic plasticity, learning, and memory. During nicotine withdrawal, NMDA receptors become overexpressed, particularly the NR2A subunit, which correlates with increased anxiety-like behaviors &lt;sup&gt;[1]&lt;/sup&gt; &lt;sup&gt;[2]&lt;/sup&gt;.

##### The NMDA Receptor-Anxiety Connection

Research indicates that NMDA receptor overactivation promotes anxiety and depression through two primary mechanisms:

* 1. Decreased protein synthesis through downregulation of the BDNF-PI3K-Akt-mTOR pathway, which impedes maintenance of synapses and growth of new neurons and synapses (processes critical for emotional regulation) &lt;sup&gt;[2]&lt;/sup&gt;.

* 2. Excessive NMDA activation leading to decreased sensitivity to dopamine in the striatum, a brain region responsible for motivation, reward, and pleasure &lt;sup&gt;[2]&lt;/sup&gt;. This diminished dopaminergic function is associated with both depression and addiction-related withdrawal symptoms.

#### Evidence for Vitamin D3&#39;s Effects on Nicotine Withdrawal

##### Animal Studies Demonstrating Efficacy

Recent research has produced compelling evidence that vitamin D3 supplementation may significantly reduce anxiety and depressive-like behaviors induced by nicotine withdrawal. A 2021 study with male C57/BL6 mice demonstrated that dietary supplementation with vitamin D3 (10,000 U/Kg) for six weeks ameliorated anxiety-like behaviors during nicotine withdrawal &lt;sup&gt;[1]&lt;/sup&gt;. Specifically, vitamin D3-treated mice showed:

* 1. Increased duration spent in the central zone during open field tests

* 2. Decreased numbers of buried marbles in marble-burying tests

* 3. Increased exploratory behavior and overall locomotor activity

These behavioral improvements indicate reduced anxiety levels during the nicotine withdrawal period in the supplemented group compared to controls &lt;sup&gt;[1]&lt;/sup&gt;.

More recently, a 2025 study with male Wistar rats further confirmed these findings, showing that vitamin D3 administration effectively prevented both anxiety and depression induced by nicotine withdrawal &lt;sup&gt;[5]&lt;/sup&gt;. This study tested various dosages (100, 1000, and 10,000 IU/kg) and found effective results, suggesting a dose-dependent response may exist &lt;sup&gt;[5]&lt;/sup&gt;.

#### Mechanisms of Vitamin D3&#39;s Anti-Anxiety Effects During Nicotine Withdrawal

##### Modulation of NMDA Receptor Expression

The most well-documented mechanism by which vitamin D3 appears to reduce withdrawal-related anxiety is through downregulation of hippocampal NR2A expression. The 2021 study demonstrated that vitamin D3 supplementation significantly attenuated both protein and mRNA levels of NR2A in the hippocampus of nicotine-withdrawn mice &lt;sup&gt;[1]&lt;/sup&gt;. This suggests that vitamin D3 may directly counteract the pathological overexpression of NMDA receptors that occurs during nicotine withdrawal.

##### Anti-inflammatory Effects

Vitamin D3 also appears to exert anti-inflammatory effects that may contribute to its anti-anxiety properties. Research on methadone maintenance treatment, while not specifically addressing nicotine withdrawal, showed that vitamin D supplementation (50,000 IU every two weeks) downregulated interleukin-1 (IL-1) expression in peripheral blood mononuclear cells &lt;sup&gt;[3]&lt;/sup&gt;. Inflammation has been increasingly linked to both anxiety and depression, suggesting another pathway by which vitamin D3 might improve withdrawal symptoms.

##### Impact on Oxidative Stress and Serotonergic Transmission

The 2025 study further expanded our understanding of vitamin D3&#39;s mechanisms by suggesting its effects may also involve modulation of oxidative stress and serotonergic transmission &lt;sup&gt;[5]&lt;/sup&gt;. While the specifics of these mechanisms require further investigation, this multi-system approach suggests vitamin D3 may address nicotine withdrawal symptoms through several complementary pathways.

#### Limitations of Current Evidence and Future Research Directions

While the evidence supporting vitamin D3&#39;s role in reducing nicotine withdrawal-induced anxiety and depression is promising, several important limitations must be acknowledged:

##### Animal vs. Human Studies

The most compelling evidence thus far comes from rodent models, with limited direct evidence in human subjects. The study on methadone maintenance treatment patients found that vitamin D supplementation did not significantly change clinical opiate withdrawal symptoms, suggesting potential differences between opiate and nicotine withdrawal or between animal and human responses &lt;sup&gt;[3]&lt;/sup&gt;.

##### Optimal Dosing and Duration (in rats and humans)

Questions remain regarding optimal dosing, timing, and duration of vitamin D3 supplementation for nicotine withdrawal. Studies have used various dosages, from 100 IU/kg to 10,000 IU/kg in animals &lt;sup&gt;[1]&lt;/sup&gt; &lt;sup&gt;[5]&lt;/sup&gt;, and 50,000 IU every two weeks in humans &lt;sup&gt;[3]&lt;/sup&gt;, without clear consensus on the ideal therapeutic approach.

##### Individual Variability

Baseline vitamin D status likely influences treatment response, but most studies have not stratified results based on pre-existing vitamin D levels. Given the high prevalence of vitamin D deficiency in many populations, including smokers, this represents an important variable for future research.

#### Clinical Implications and Practical Applications

Despite these limitations, the existing evidence suggests several potential clinical applications:

##### Adjunctive Therapy for Smoking Cessation

Vitamin D3 supplementation could potentially serve as a safe, accessible adjunctive therapy alongside existing smoking cessation approaches. Given the relatively benign side effect profile of appropriate vitamin D supplementation, it represents a low-risk intervention that might enhance quit rates by reducing withdrawal-related anxiety and depression.

##### Targeted Approach for Vulnerable Populations

The anxiety and depression associated with nicotine withdrawal may be particularly challenging for individuals with pre-existing mental health conditions. For these vulnerable populations, vitamin D3 supplementation might offer specific benefits, though targeted studies are needed.

##### Integration with Existing Approaches

Rather than a standalone treatment, vitamin D3 supplementation could complement existing strategies, including behavioral therapy, nicotine replacement therapy, and other pharmacological interventions. The potential synergistic effects of combining these approaches warrant further investigation.

#### Conclusion

The current evidence suggests that vitamin D3 supplementation shows promise for reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. The primary mechanism appears to involve downregulation of NR2A expression in the hippocampus, counteracting the pathological NMDA receptor overactivation that occurs during withdrawal. Additional benefits may stem from vitamin D3&#39;s anti-inflammatory properties and effects on oxidative stress and serotonergic transmission.

While more research is needed, particularly human clinical trials with standardized dosing protocols and attention to baseline vitamin D status, the existing evidence provides a compelling rationale for further investigation of vitamin D3 as a supportive intervention for individuals navigating the challenging process of nicotine withdrawal. For those attempting to quit smoking, especially individuals prone to anxiety or depression, vitamin D3 supplementation may represent a valuable addition to their cessation toolkit.

##### Citations:

&lt;sup&gt;[1]&lt;/sup&gt; https://pmc.ncbi.nlm.nih.gov/articles/PMC8200643/

&lt;sup&gt;[2]&lt;/sup&gt; https://www.reddit.com/r/Nootropics/comments/pqpww1/vitamin_d3_reduces_hippocampal_nmdanr2a_and/

&lt;sup&gt;[3]&lt;/sup&gt; https://brieflands.com/articles/ijpbs-86969

&lt;sup&gt;[4]&lt;/sup&gt; https://www.verywellmind.com/what-to-expect-from-nicotine-withdrawal-22467

&lt;sup&gt;[5]&lt;/sup&gt; https://www.tandfonline.com/doi/full/10.1080/13813455.2025.2483508  (Rats: April 2025 $$$ paywall)

&lt;sup&gt;[6]&lt;/sup&gt; https://www.healthline.com/health/smoking/nicotine-withdrawal

&lt;sup&gt;[7]&lt;/sup&gt; https://www.sciencedirect.com/science/article/abs/pii/S0006295223004239

&lt;sup&gt;[8]&lt;/sup&gt; https://www.sciencedirect.com/science/article/pii/S277239252400049X

&lt;sup&gt;[9]&lt;/sup&gt; https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805442

&lt;sup&gt;[10]&lt;/sup&gt; https://www.optimallivingdynamics.com/blog/9-nutrients-proven-to-help-you-overcome-addiction-and-withdrawal-nutrition-recovery-vitamins-minerals-amino-acid-symptoms-supplements-diet-substance-drug-abuse-syndrome-cravings-opiate-alcoholism-food

&lt;sup&gt;[11]&lt;/sup&gt; https://pubmed.ncbi.nlm.nih.gov/40198132/

&lt;sup&gt;[12]&lt;/sup&gt; https://www.physio-pedia.com/Vitamin_D_and_the_Effect_on_Mental_Health

&lt;sup&gt;[13]&lt;/sup&gt; https://www.sciencedirect.com/science/article/pii/S2772392525000057

&lt;sup&gt;[14]&lt;/sup&gt; https://reactionrecovery.com/nicotine/


AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!The Role of Vitamin D3 in Alleviating Anxiety and Depression During Nicotine Withdrawal`
│   inner_content: `The Role of Vitamin D3 in Alleviating Anxiety and Depression During Nicotine Withdrawal`
│   level: `3`
│   children:
│   ├── TextNode
│   │   full_match: `The Role of Vitamin D3 in Alleviating Anxiety and Depression During Nicotine Withdrawal`
│   │   inner_content: `The Role of Vitamin D3 in Alleviating Anxiety and Depression During Nicotine Withdrawal`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__[https://www.perplexity.ai/search/do-3-hours-of-screen-time-dail-wcnSkHdaSquT2OjKIIoO.g|Perplexity AI - Deep Research April 2025]__`
│   inner_content: `[https://www.perplexity.ai/search/do-3-hours-of-screen-time-dail-wcnSkHdaSquT2OjKIIoO.g|Perplexity AI - Deep Research April 2025]`
│   children:
│   ├── LinkNode
│   │   full_match: `[https://www.perplexity.ai/search/do-3-hours-of-screen-time-dail-wcnSkHdaSquT2OjKIIoO.g|Perplexity AI - Deep Research April 2025]`
│   │   inner_content: `Perplexity AI - Deep Research April 2025`
│   │   url: `https://www.perplexity.ai/search/do-3-hours-of-screen-time-dail-wcnSkHdaSquT2OjKIIoO.g`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Perplexity AI - Deep Research April 2025`
│   │   │   inner_content: `Perplexity AI - Deep Research April 2025`├── TextNode
│   full_match: `\nRecent scientific evidence suggests that vitamin D3 supplementation may have significant potential in reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. This report examines the existing research on this relationship, exploring both the neurobiological mechanisms and clinical implications of vitamin D3 as a potential adjunctive therapy for individuals attempting to quit smoking.\n`
│   inner_content: `\nRecent scientific evidence suggests that vitamin D3 supplementation may have significant potential in reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. This report examines the existing research on this relationship, exploring both the neurobiological mechanisms and clinical implications of vitamin D3 as a potential adjunctive therapy for individuals attempting to quit smoking.\n`├── HeadingNode
│   full_match: `!!!! Understanding Nicotine Withdrawal and Its Neurobiological Basis`
│   inner_content: `Understanding Nicotine Withdrawal and Its Neurobiological Basis`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Understanding Nicotine Withdrawal and Its Neurobiological Basis`
│   │   inner_content: `Understanding Nicotine Withdrawal and Its Neurobiological Basis`├── TextNode
│   full_match: `\nNicotine withdrawal represents a significant challenge for individuals attempting to quit smoking, with symptoms typically beginning within 30 minutes of the last cigarette and peaking within the first three to seven days. These symptoms can persist for weeks or even months, significantly increasing the risk of relapse `
│   inner_content: `\nNicotine withdrawal represents a significant challenge for individuals attempting to quit smoking, with symptoms typically beginning within 30 minutes of the last cigarette and peaking within the first three to seven days. These symptoms can persist for weeks or even months, significantly increasing the risk of relapse `├── LinkNode
│   full_match: `[4]`
│   inner_content: `4`
│   url: `4`
│   children:
│   ├── TextNode
│   │   full_match: `4`
│   │   inner_content: `4`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── LinkNode
│   full_match: `[6]`
│   inner_content: `6`
│   url: `6`
│   children:
│   ├── TextNode
│   │   full_match: `6`
│   │   inner_content: `6`├── TextNode
│   full_match: `. Common nicotine withdrawal symptoms include intense cravings, anxiety, irritability, depressed mood, difficulty concentrating, insomnia, and restlessness `
│   inner_content: `. Common nicotine withdrawal symptoms include intense cravings, anxiety, irritability, depressed mood, difficulty concentrating, insomnia, and restlessness `├── LinkNode
│   full_match: `[4]`
│   inner_content: `4`
│   url: `4`
│   children:
│   ├── TextNode
│   │   full_match: `4`
│   │   inner_content: `4`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── LinkNode
│   full_match: `[6]`
│   inner_content: `6`
│   url: `6`
│   children:
│   ├── TextNode
│   │   full_match: `6`
│   │   inner_content: `6`├── TextNode
│   full_match: `. \nThe neurobiological underpinnings of nicotine withdrawal-induced anxiety and depression are complex and involve multiple neurotransmitter systems. One critical mechanism appears to involve the N-Methyl-D-aspartate (NMDA) receptor, a glutamate receptor that plays a significant role in synaptic plasticity, learning, and memory. During nicotine withdrawal, NMDA receptors become overexpressed, particularly the NR2A subunit, which correlates with increased anxiety-like behaviors `
│   inner_content: `. \nThe neurobiological underpinnings of nicotine withdrawal-induced anxiety and depression are complex and involve multiple neurotransmitter systems. One critical mechanism appears to involve the N-Methyl-D-aspartate (NMDA) receptor, a glutamate receptor that plays a significant role in synaptic plasticity, learning, and memory. During nicotine withdrawal, NMDA receptors become overexpressed, particularly the NR2A subunit, which correlates with increased anxiety-like behaviors `├── LinkNode
│   full_match: `[1]`
│   inner_content: `1`
│   url: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1`
│   │   inner_content: `1`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── LinkNode
│   full_match: `[2]`
│   inner_content: `2`
│   url: `2`
│   children:
│   ├── TextNode
│   │   full_match: `2`
│   │   inner_content: `2`├── TextNode
│   full_match: `.\n`
│   inner_content: `.\n`├── HeadingNode
│   full_match: `!!!!! The NMDA Receptor-Anxiety Connection`
│   inner_content: `The NMDA Receptor-Anxiety Connection`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `The NMDA Receptor-Anxiety Connection`
│   │   inner_content: `The NMDA Receptor-Anxiety Connection`├── TextNode
│   full_match: `\nResearch indicates that NMDA receptor overactivation promotes anxiety and depression through two primary mechanisms:\n`
│   inner_content: `\nResearch indicates that NMDA receptor overactivation promotes anxiety and depression through two primary mechanisms:\n`├── ListItemNode
│   full_match: `*1. Decreased protein synthesis through downregulation of the BDNF-PI3K-Akt-mTOR pathway, which impedes maintenance of synapses and growth of new neurons and synapses (processes critical for emotional regulation) [2].`
│   inner_content: `1. Decreased protein synthesis through downregulation of the BDNF-PI3K-Akt-mTOR pathway, which impedes maintenance of synapses and growth of new neurons and synapses (processes critical for emotional regulation) [2].`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1. Decreased protein synthesis through downregulation of the BDNF-PI3K-Akt-mTOR pathway, which impedes maintenance of synapses and growth of new neurons and synapses (processes critical for emotional regulation) `
│   │   inner_content: `1. Decreased protein synthesis through downregulation of the BDNF-PI3K-Akt-mTOR pathway, which impedes maintenance of synapses and growth of new neurons and synapses (processes critical for emotional regulation) `
│   ├── LinkNode
│   │   full_match: `[2]`
│   │   inner_content: `2`
│   │   url: `2`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `2`
│   │   │   inner_content: `2`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*2. Excessive NMDA activation leading to decreased sensitivity to dopamine in the striatum, a brain region responsible for motivation, reward, and pleasure [2]. This diminished dopaminergic function is associated with both depression and addiction-related withdrawal symptoms.`
│   inner_content: `2. Excessive NMDA activation leading to decreased sensitivity to dopamine in the striatum, a brain region responsible for motivation, reward, and pleasure [2]. This diminished dopaminergic function is associated with both depression and addiction-related withdrawal symptoms.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `2. Excessive NMDA activation leading to decreased sensitivity to dopamine in the striatum, a brain region responsible for motivation, reward, and pleasure `
│   │   inner_content: `2. Excessive NMDA activation leading to decreased sensitivity to dopamine in the striatum, a brain region responsible for motivation, reward, and pleasure `
│   ├── LinkNode
│   │   full_match: `[2]`
│   │   inner_content: `2`
│   │   url: `2`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `2`
│   │   │   inner_content: `2`
│   ├── TextNode
│   │   full_match: `. This diminished dopaminergic function is associated with both depression and addiction-related withdrawal symptoms.`
│   │   inner_content: `. This diminished dopaminergic function is associated with both depression and addiction-related withdrawal symptoms.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── HeadingNode
│   full_match: `!!!! Evidence for Vitamin D3&#39;s Effects on Nicotine Withdrawal`
│   inner_content: `Evidence for Vitamin D3&#39;s Effects on Nicotine Withdrawal`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Evidence for Vitamin D3&#39;s Effects on Nicotine Withdrawal`
│   │   inner_content: `Evidence for Vitamin D3&#39;s Effects on Nicotine Withdrawal`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── HeadingNode
│   full_match: `!!!!! Animal Studies Demonstrating Efficacy`
│   inner_content: `Animal Studies Demonstrating Efficacy`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Animal Studies Demonstrating Efficacy`
│   │   inner_content: `Animal Studies Demonstrating Efficacy`├── TextNode
│   full_match: `\nRecent research has produced compelling evidence that vitamin D3 supplementation may significantly reduce anxiety and depressive-like behaviors induced by nicotine withdrawal. A 2021 study with male C57/BL6 mice demonstrated that dietary supplementation with vitamin D3 (10,000 U/Kg) for six weeks ameliorated anxiety-like behaviors during nicotine withdrawal `
│   inner_content: `\nRecent research has produced compelling evidence that vitamin D3 supplementation may significantly reduce anxiety and depressive-like behaviors induced by nicotine withdrawal. A 2021 study with male C57/BL6 mice demonstrated that dietary supplementation with vitamin D3 (10,000 U/Kg) for six weeks ameliorated anxiety-like behaviors during nicotine withdrawal `├── LinkNode
│   full_match: `[1]`
│   inner_content: `1`
│   url: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1`
│   │   inner_content: `1`├── TextNode
│   full_match: `. Specifically, vitamin D3-treated mice showed:\n`
│   inner_content: `. Specifically, vitamin D3-treated mice showed:\n`├── ListItemNode
│   full_match: `*1. Increased duration spent in the central zone during open field tests`
│   inner_content: `1. Increased duration spent in the central zone during open field tests`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1. Increased duration spent in the central zone during open field tests`
│   │   inner_content: `1. Increased duration spent in the central zone during open field tests`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*2. Decreased numbers of buried marbles in marble-burying tests`
│   inner_content: `2. Decreased numbers of buried marbles in marble-burying tests`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `2. Decreased numbers of buried marbles in marble-burying tests`
│   │   inner_content: `2. Decreased numbers of buried marbles in marble-burying tests`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*3. Increased exploratory behavior and overall locomotor activity`
│   inner_content: `3. Increased exploratory behavior and overall locomotor activity`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `3. Increased exploratory behavior and overall locomotor activity`
│   │   inner_content: `3. Increased exploratory behavior and overall locomotor activity`├── TextNode
│   full_match: `\nThese behavioral improvements indicate reduced anxiety levels during the nicotine withdrawal period in the supplemented group compared to controls `
│   inner_content: `\nThese behavioral improvements indicate reduced anxiety levels during the nicotine withdrawal period in the supplemented group compared to controls `├── LinkNode
│   full_match: `[1]`
│   inner_content: `1`
│   url: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1`
│   │   inner_content: `1`├── TextNode
│   full_match: `.\nMore recently, a 2025 study with male Wistar rats further confirmed these findings, showing that vitamin D3 administration effectively prevented both anxiety and depression induced by nicotine withdrawal `
│   inner_content: `.\nMore recently, a 2025 study with male Wistar rats further confirmed these findings, showing that vitamin D3 administration effectively prevented both anxiety and depression induced by nicotine withdrawal `├── LinkNode
│   full_match: `[5]`
│   inner_content: `5`
│   url: `5`
│   children:
│   ├── TextNode
│   │   full_match: `5`
│   │   inner_content: `5`├── TextNode
│   full_match: `. This study tested various dosages (100, 1000, and 10,000 IU/kg) and found effective results, suggesting a dose-dependent response may exist `
│   inner_content: `. This study tested various dosages (100, 1000, and 10,000 IU/kg) and found effective results, suggesting a dose-dependent response may exist `├── LinkNode
│   full_match: `[5]`
│   inner_content: `5`
│   url: `5`
│   children:
│   ├── TextNode
│   │   full_match: `5`
│   │   inner_content: `5`├── TextNode
│   full_match: `.\n`
│   inner_content: `.\n`├── HeadingNode
│   full_match: `!!!! Mechanisms of Vitamin D3&#39;s Anti-Anxiety Effects During Nicotine Withdrawal`
│   inner_content: `Mechanisms of Vitamin D3&#39;s Anti-Anxiety Effects During Nicotine Withdrawal`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Mechanisms of Vitamin D3&#39;s Anti-Anxiety Effects During Nicotine Withdrawal`
│   │   inner_content: `Mechanisms of Vitamin D3&#39;s Anti-Anxiety Effects During Nicotine Withdrawal`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── HeadingNode
│   full_match: `!!!!! Modulation of NMDA Receptor Expression`
│   inner_content: `Modulation of NMDA Receptor Expression`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Modulation of NMDA Receptor Expression`
│   │   inner_content: `Modulation of NMDA Receptor Expression`├── TextNode
│   full_match: `\nThe most well-documented mechanism by which vitamin D3 appears to reduce withdrawal-related anxiety is through downregulation of hippocampal NR2A expression. The 2021 study demonstrated that vitamin D3 supplementation significantly attenuated both protein and mRNA levels of NR2A in the hippocampus of nicotine-withdrawn mice `
│   inner_content: `\nThe most well-documented mechanism by which vitamin D3 appears to reduce withdrawal-related anxiety is through downregulation of hippocampal NR2A expression. The 2021 study demonstrated that vitamin D3 supplementation significantly attenuated both protein and mRNA levels of NR2A in the hippocampus of nicotine-withdrawn mice `├── LinkNode
│   full_match: `[1]`
│   inner_content: `1`
│   url: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1`
│   │   inner_content: `1`├── TextNode
│   full_match: `. This suggests that vitamin D3 may directly counteract the pathological overexpression of NMDA receptors that occurs during nicotine withdrawal.\n`
│   inner_content: `. This suggests that vitamin D3 may directly counteract the pathological overexpression of NMDA receptors that occurs during nicotine withdrawal.\n`├── HeadingNode
│   full_match: `!!!!! Anti-inflammatory Effects`
│   inner_content: `Anti-inflammatory Effects`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Anti-inflammatory Effects`
│   │   inner_content: `Anti-inflammatory Effects`├── TextNode
│   full_match: `\nVitamin D3 also appears to exert anti-inflammatory effects that may contribute to its anti-anxiety properties. Research on methadone maintenance treatment, while not specifically addressing nicotine withdrawal, showed that vitamin D supplementation (50,000 IU every two weeks) downregulated interleukin-1 (IL-1) expression in peripheral blood mononuclear cells `
│   inner_content: `\nVitamin D3 also appears to exert anti-inflammatory effects that may contribute to its anti-anxiety properties. Research on methadone maintenance treatment, while not specifically addressing nicotine withdrawal, showed that vitamin D supplementation (50,000 IU every two weeks) downregulated interleukin-1 (IL-1) expression in peripheral blood mononuclear cells `├── LinkNode
│   full_match: `[3]`
│   inner_content: `3`
│   url: `3`
│   children:
│   ├── TextNode
│   │   full_match: `3`
│   │   inner_content: `3`├── TextNode
│   full_match: `. Inflammation has been increasingly linked to both anxiety and depression, suggesting another pathway by which vitamin D3 might improve withdrawal symptoms.\n`
│   inner_content: `. Inflammation has been increasingly linked to both anxiety and depression, suggesting another pathway by which vitamin D3 might improve withdrawal symptoms.\n`├── HeadingNode
│   full_match: `!!!!! Impact on Oxidative Stress and Serotonergic Transmission`
│   inner_content: `Impact on Oxidative Stress and Serotonergic Transmission`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Impact on Oxidative Stress and Serotonergic Transmission`
│   │   inner_content: `Impact on Oxidative Stress and Serotonergic Transmission`├── TextNode
│   full_match: `\nThe 2025 study further expanded our understanding of vitamin D3&#39;s mechanisms by suggesting its effects may also involve modulation of oxidative stress and serotonergic transmission `
│   inner_content: `\nThe 2025 study further expanded our understanding of vitamin D3&#39;s mechanisms by suggesting its effects may also involve modulation of oxidative stress and serotonergic transmission `├── LinkNode
│   full_match: `[5]`
│   inner_content: `5`
│   url: `5`
│   children:
│   ├── TextNode
│   │   full_match: `5`
│   │   inner_content: `5`├── TextNode
│   full_match: `. While the specifics of these mechanisms require further investigation, this multi-system approach suggests vitamin D3 may address nicotine withdrawal symptoms through several complementary pathways.\n`
│   inner_content: `. While the specifics of these mechanisms require further investigation, this multi-system approach suggests vitamin D3 may address nicotine withdrawal symptoms through several complementary pathways.\n`├── HeadingNode
│   full_match: `!!!! Limitations of Current Evidence and Future Research Directions`
│   inner_content: `Limitations of Current Evidence and Future Research Directions`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Limitations of Current Evidence and Future Research Directions`
│   │   inner_content: `Limitations of Current Evidence and Future Research Directions`├── TextNode
│   full_match: `\nWhile the evidence supporting vitamin D3&#39;s role in reducing nicotine withdrawal-induced anxiety and depression is promising, several important limitations must be acknowledged:\n`
│   inner_content: `\nWhile the evidence supporting vitamin D3&#39;s role in reducing nicotine withdrawal-induced anxiety and depression is promising, several important limitations must be acknowledged:\n`├── HeadingNode
│   full_match: `!!!!! Animal vs. Human Studies`
│   inner_content: `Animal vs. Human Studies`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Animal vs. Human Studies`
│   │   inner_content: `Animal vs. Human Studies`├── TextNode
│   full_match: `\nThe most compelling evidence thus far comes from rodent models, with limited direct evidence in human subjects. The study on methadone maintenance treatment patients found that vitamin D supplementation did not significantly change clinical opiate withdrawal symptoms, suggesting potential differences between opiate and nicotine withdrawal or between animal and human responses `
│   inner_content: `\nThe most compelling evidence thus far comes from rodent models, with limited direct evidence in human subjects. The study on methadone maintenance treatment patients found that vitamin D supplementation did not significantly change clinical opiate withdrawal symptoms, suggesting potential differences between opiate and nicotine withdrawal or between animal and human responses `├── LinkNode
│   full_match: `[3]`
│   inner_content: `3`
│   url: `3`
│   children:
│   ├── TextNode
│   │   full_match: `3`
│   │   inner_content: `3`├── TextNode
│   full_match: `.\n`
│   inner_content: `.\n`├── HeadingNode
│   full_match: `!!!!! Optimal Dosing and Duration (in rats and humans)`
│   inner_content: `Optimal Dosing and Duration (in rats and humans)`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Optimal Dosing and Duration (in rats and humans)`
│   │   inner_content: `Optimal Dosing and Duration (in rats and humans)`├── TextNode
│   full_match: `\nQuestions remain regarding optimal dosing, timing, and duration of vitamin D3 supplementation for nicotine withdrawal. Studies have used various dosages, from 100 IU/kg to 10,000 IU/kg in animals `
│   inner_content: `\nQuestions remain regarding optimal dosing, timing, and duration of vitamin D3 supplementation for nicotine withdrawal. Studies have used various dosages, from 100 IU/kg to 10,000 IU/kg in animals `├── LinkNode
│   full_match: `[1]`
│   inner_content: `1`
│   url: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1`
│   │   inner_content: `1`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── LinkNode
│   full_match: `[5]`
│   inner_content: `5`
│   url: `5`
│   children:
│   ├── TextNode
│   │   full_match: `5`
│   │   inner_content: `5`├── TextNode
│   full_match: `, and 50,000 IU every two weeks in humans `
│   inner_content: `, and 50,000 IU every two weeks in humans `├── LinkNode
│   full_match: `[3]`
│   inner_content: `3`
│   url: `3`
│   children:
│   ├── TextNode
│   │   full_match: `3`
│   │   inner_content: `3`├── TextNode
│   full_match: `, without clear consensus on the ideal therapeutic approach.\n`
│   inner_content: `, without clear consensus on the ideal therapeutic approach.\n`├── HeadingNode
│   full_match: `!!!!! Individual Variability`
│   inner_content: `Individual Variability`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Individual Variability`
│   │   inner_content: `Individual Variability`├── TextNode
│   full_match: `\nBaseline vitamin D status likely influences treatment response, but most studies have not stratified results based on pre-existing vitamin D levels. Given the high prevalence of vitamin D deficiency in many populations, including smokers, this represents an important variable for future research.\n`
│   inner_content: `\nBaseline vitamin D status likely influences treatment response, but most studies have not stratified results based on pre-existing vitamin D levels. Given the high prevalence of vitamin D deficiency in many populations, including smokers, this represents an important variable for future research.\n`├── HeadingNode
│   full_match: `!!!! Clinical Implications and Practical Applications`
│   inner_content: `Clinical Implications and Practical Applications`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Clinical Implications and Practical Applications`
│   │   inner_content: `Clinical Implications and Practical Applications`├── TextNode
│   full_match: `\nDespite these limitations, the existing evidence suggests several potential clinical applications:\n`
│   inner_content: `\nDespite these limitations, the existing evidence suggests several potential clinical applications:\n`├── HeadingNode
│   full_match: `!!!!! Adjunctive Therapy for Smoking Cessation`
│   inner_content: `Adjunctive Therapy for Smoking Cessation`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Adjunctive Therapy for Smoking Cessation`
│   │   inner_content: `Adjunctive Therapy for Smoking Cessation`├── TextNode
│   full_match: `\nVitamin D3 supplementation could potentially serve as a safe, accessible adjunctive therapy alongside existing smoking cessation approaches. Given the relatively benign side effect profile of appropriate vitamin D supplementation, it represents a low-risk intervention that might enhance quit rates by reducing withdrawal-related anxiety and depression.\n`
│   inner_content: `\nVitamin D3 supplementation could potentially serve as a safe, accessible adjunctive therapy alongside existing smoking cessation approaches. Given the relatively benign side effect profile of appropriate vitamin D supplementation, it represents a low-risk intervention that might enhance quit rates by reducing withdrawal-related anxiety and depression.\n`├── HeadingNode
│   full_match: `!!!!! Targeted Approach for Vulnerable Populations`
│   inner_content: `Targeted Approach for Vulnerable Populations`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Targeted Approach for Vulnerable Populations`
│   │   inner_content: `Targeted Approach for Vulnerable Populations`├── TextNode
│   full_match: `\nThe anxiety and depression associated with nicotine withdrawal may be particularly challenging for individuals with pre-existing mental health conditions. For these vulnerable populations, vitamin D3 supplementation might offer specific benefits, though targeted studies are needed.\n`
│   inner_content: `\nThe anxiety and depression associated with nicotine withdrawal may be particularly challenging for individuals with pre-existing mental health conditions. For these vulnerable populations, vitamin D3 supplementation might offer specific benefits, though targeted studies are needed.\n`├── HeadingNode
│   full_match: `!!!!! Integration with Existing Approaches`
│   inner_content: `Integration with Existing Approaches`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Integration with Existing Approaches`
│   │   inner_content: `Integration with Existing Approaches`├── TextNode
│   full_match: `\nRather than a standalone treatment, vitamin D3 supplementation could complement existing strategies, including behavioral therapy, nicotine replacement therapy, and other pharmacological interventions. The potential synergistic effects of combining these approaches warrant further investigation.\n`
│   inner_content: `\nRather than a standalone treatment, vitamin D3 supplementation could complement existing strategies, including behavioral therapy, nicotine replacement therapy, and other pharmacological interventions. The potential synergistic effects of combining these approaches warrant further investigation.\n`├── HeadingNode
│   full_match: `!!!! Conclusion`
│   inner_content: `Conclusion`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Conclusion`
│   │   inner_content: `Conclusion`├── TextNode
│   full_match: `\nThe current evidence suggests that vitamin D3 supplementation shows promise for reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. The primary mechanism appears to involve downregulation of NR2A expression in the hippocampus, counteracting the pathological NMDA receptor overactivation that occurs during withdrawal. Additional benefits may stem from vitamin D3&#39;s anti-inflammatory properties and effects on oxidative stress and serotonergic transmission.\nWhile more research is needed, particularly human clinical trials with standardized dosing protocols and attention to baseline vitamin D status, the existing evidence provides a compelling rationale for further investigation of vitamin D3 as a supportive intervention for individuals navigating the challenging process of nicotine withdrawal. For those attempting to quit smoking, especially individuals prone to anxiety or depression, vitamin D3 supplementation may represent a valuable addition to their cessation toolkit.\n`
│   inner_content: `\nThe current evidence suggests that vitamin D3 supplementation shows promise for reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. The primary mechanism appears to involve downregulation of NR2A expression in the hippocampus, counteracting the pathological NMDA receptor overactivation that occurs during withdrawal. Additional benefits may stem from vitamin D3&#39;s anti-inflammatory properties and effects on oxidative stress and serotonergic transmission.\nWhile more research is needed, particularly human clinical trials with standardized dosing protocols and attention to baseline vitamin D status, the existing evidence provides a compelling rationale for further investigation of vitamin D3 as a supportive intervention for individuals navigating the challenging process of nicotine withdrawal. For those attempting to quit smoking, especially individuals prone to anxiety or depression, vitamin D3 supplementation may represent a valuable addition to their cessation toolkit.\n`├── HeadingNode
│   full_match: `!!!!!Citations:`
│   inner_content: `Citations:`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Citations:`
│   │   inner_content: `Citations:`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── LinkNode
│   full_match: `[1]`
│   inner_content: `1`
│   url: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1`
│   │   inner_content: `1`├── TextNode
│   full_match: ` https://pmc.ncbi.nlm.nih.gov/articles/PMC8200643/\n`
│   inner_content: ` https://pmc.ncbi.nlm.nih.gov/articles/PMC8200643/\n`├── LinkNode
│   full_match: `[2]`
│   inner_content: `2`
│   url: `2`
│   children:
│   ├── TextNode
│   │   full_match: `2`
│   │   inner_content: `2`├── TextNode
│   full_match: ` https://www.reddit.com/r/Nootropics/comments/pqpww1/vitamin_d3_reduces_hippocampal_nmdanr2a_and/\n`
│   inner_content: ` https://www.reddit.com/r/Nootropics/comments/pqpww1/vitamin_d3_reduces_hippocampal_nmdanr2a_and/\n`├── LinkNode
│   full_match: `[3]`
│   inner_content: `3`
│   url: `3`
│   children:
│   ├── TextNode
│   │   full_match: `3`
│   │   inner_content: `3`├── TextNode
│   full_match: ` https://brieflands.com/articles/ijpbs-86969\n`
│   inner_content: ` https://brieflands.com/articles/ijpbs-86969\n`├── LinkNode
│   full_match: `[4]`
│   inner_content: `4`
│   url: `4`
│   children:
│   ├── TextNode
│   │   full_match: `4`
│   │   inner_content: `4`├── TextNode
│   full_match: ` https://www.verywellmind.com/what-to-expect-from-nicotine-withdrawal-22467\n`
│   inner_content: ` https://www.verywellmind.com/what-to-expect-from-nicotine-withdrawal-22467\n`├── LinkNode
│   full_match: `[5]`
│   inner_content: `5`
│   url: `5`
│   children:
│   ├── TextNode
│   │   full_match: `5`
│   │   inner_content: `5`├── TextNode
│   full_match: ` https://www.tandfonline.com/doi/full/10.1080/13813455.2025.2483508  (Rats: April 2025 $$$ paywall)\n`
│   inner_content: ` https://www.tandfonline.com/doi/full/10.1080/13813455.2025.2483508  (Rats: April 2025 $$$ paywall)\n`├── LinkNode
│   full_match: `[6]`
│   inner_content: `6`
│   url: `6`
│   children:
│   ├── TextNode
│   │   full_match: `6`
│   │   inner_content: `6`├── TextNode
│   full_match: ` https://www.healthline.com/health/smoking/nicotine-withdrawal\n`
│   inner_content: ` https://www.healthline.com/health/smoking/nicotine-withdrawal\n`├── LinkNode
│   full_match: `[7]`
│   inner_content: `7`
│   url: `7`
│   children:
│   ├── TextNode
│   │   full_match: `7`
│   │   inner_content: `7`├── TextNode
│   full_match: ` https://www.sciencedirect.com/science/article/abs/pii/S0006295223004239\n`
│   inner_content: ` https://www.sciencedirect.com/science/article/abs/pii/S0006295223004239\n`├── LinkNode
│   full_match: `[8]`
│   inner_content: `8`
│   url: `8`
│   children:
│   ├── TextNode
│   │   full_match: `8`
│   │   inner_content: `8`├── TextNode
│   full_match: ` https://www.sciencedirect.com/science/article/pii/S277239252400049X\n`
│   inner_content: ` https://www.sciencedirect.com/science/article/pii/S277239252400049X\n`├── LinkNode
│   full_match: `[9]`
│   inner_content: `9`
│   url: `9`
│   children:
│   ├── TextNode
│   │   full_match: `9`
│   │   inner_content: `9`├── TextNode
│   full_match: ` https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805442\n`
│   inner_content: ` https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805442\n`├── LinkNode
│   full_match: `[10]`
│   inner_content: `10`
│   url: `10`
│   children:
│   ├── TextNode
│   │   full_match: `10`
│   │   inner_content: `10`├── TextNode
│   full_match: ` https://www.optimallivingdynamics.com/blog/9-nutrients-proven-to-help-you-overcome-addiction-and-withdrawal-nutrition-recovery-vitamins-minerals-amino-acid-symptoms-supplements-diet-substance-drug-abuse-syndrome-cravings-opiate-alcoholism-food\n`
│   inner_content: ` https://www.optimallivingdynamics.com/blog/9-nutrients-proven-to-help-you-overcome-addiction-and-withdrawal-nutrition-recovery-vitamins-minerals-amino-acid-symptoms-supplements-diet-substance-drug-abuse-syndrome-cravings-opiate-alcoholism-food\n`├── LinkNode
│   full_match: `[11]`
│   inner_content: `11`
│   url: `11`
│   children:
│   ├── TextNode
│   │   full_match: `11`
│   │   inner_content: `11`├── TextNode
│   full_match: ` https://pubmed.ncbi.nlm.nih.gov/40198132/\n`
│   inner_content: ` https://pubmed.ncbi.nlm.nih.gov/40198132/\n`├── LinkNode
│   full_match: `[12]`
│   inner_content: `12`
│   url: `12`
│   children:
│   ├── TextNode
│   │   full_match: `12`
│   │   inner_content: `12`├── TextNode
│   full_match: ` https://www.physio-pedia.com/Vitamin_D_and_the_Effect_on_Mental_Health\n`
│   inner_content: ` https://www.physio-pedia.com/Vitamin_D_and_the_Effect_on_Mental_Health\n`├── LinkNode
│   full_match: `[13]`
│   inner_content: `13`
│   url: `13`
│   children:
│   ├── TextNode
│   │   full_match: `13`
│   │   inner_content: `13`├── TextNode
│   full_match: ` https://www.sciencedirect.com/science/article/pii/S2772392525000057\n`
│   inner_content: ` https://www.sciencedirect.com/science/article/pii/S2772392525000057\n`├── LinkNode
│   full_match: `[14]`
│   inner_content: `14`
│   url: `14`
│   children:
│   ├── TextNode
│   │   full_match: `14`
│   │   inner_content: `14`├── TextNode
│   full_match: ` https://reactionrecovery.com/nicotine/`
│   inner_content: ` https://reactionrecovery.com/nicotine/`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Smoking reduces vitamin D - many studies)) contains:`
│   inner_content: `VitaminDWiki – ((Smoking reduces vitamin D - many studies)) contains:`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Smoking reduces vitamin D - many studies))`
│   │   inner_content: `Smoking reduces vitamin D - many studies`
│   │   page: `Smoking reduces vitamin D - many studies`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Smoking reduces vitamin D - many studies`
│   │   │   inner_content: `Smoking reduces vitamin D - many studies`
│   ├── TextNode
│   │   full_match: ` contains:`
│   │   inner_content: ` contains:`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Smoking reduces vitamin D - many studies&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Smoking reduces vitamin D - many studies&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Smoking reduces vitamin D - many studies
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!! {SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 97  OR categId = 48 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL} Interventions for Depression`
│   inner_content: `{SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 97  OR categId = 48 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL} Interventions for Depression`
│   level: `4`
│   children:
│   ├── SqlNode
│   │   full_match: `{SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 97  OR categId = 48 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL}`
│   │   inner_content: `SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 97  OR categId = 48 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;`
│   │   attrs_dict:
│   │   │   raw_content: db=&gt;vitamind
│   │   │   db: &gt;vitamind
│   ├── TextNode
│   │   full_match: ` Interventions for Depression`
│   │   inner_content: ` Interventions for Depression`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── CategoryNode
│   full_match: `{category id=&quot;97+48&quot; types=&quot;wiki&quot; sort=&quot;created_desc&quot; split=&quot;n&quot; and=&quot;y&quot; sub=&quot;n&quot; showdescription=&quot;n&quot; showname=&quot;y&quot; showtype=&quot;n&quot; one=&quot;y&quot; showTitle=&quot;n&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: id=&quot;97+48&quot; types=&quot;wiki&quot; sort=&quot;created_desc&quot; split=&quot;n&quot; and=&quot;y&quot; sub=&quot;n&quot; showdescription=&quot;n&quot; showname=&quot;y&quot; showtype=&quot;n&quot; one=&quot;y&quot; showTitle=&quot;n&quot;
│   │   id: 97+48
│   │   types: wiki
│   │   sort: created_desc
│   │   split: n
│   │   and: y
│   │   sub: n
│   │   showdescription: n
│   │   showname: y
│   │   showtype: n
│   │   one: y
│   │   showTitle: n├── TextNode
│   full_match: `  \n`
│   inner_content: `  \n`├── TikiCommentNode
│   full_match: `~tc~ (alias(Stopping smloing increases depression and anxiety, Vitamin D helps (in mice so far)) ~/tc~`
│   inner_content: ` (alias(Stopping smloing increases depression and anxiety, Vitamin D helps (in mice so far)) `
│   children:
│   ├── TextNode
│   │   full_match: `(alias(Stopping smloing increases depression and anxiety, Vitamin D helps (in mice so far)) `
│   │   inner_content: `(alias(Stopping smloing increases depression and anxiety, Vitamin D helps (in mice so far)) `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── TikiCommentNode
│   full_match: `~tc~ (alias(Stopping smoking increases depression and anxiety if not increase Vitamin D)) ~/tc~`
│   inner_content: ` (alias(Stopping smoking increases depression and anxiety if not increase Vitamin D)) `
│   children:
│   ├── TextNode
│   │   full_match: `(alias(Stopping smoking increases depression and anxiety if not increase Vitamin D)) `
│   │   inner_content: `(alias(Stopping smoking increases depression and anxiety if not increase Vitamin D)) `

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!The Role of Vitamin D3 in Alleviating Anxiety and Depression During Nicotine Withdrawal
__[https://www.perplexity.ai/search/do-3-hours-of-screen-time-dail-wcnSkHdaSquT2OjKIIoO.g|Perplexity AI - Deep Research April 2025]__
Recent scientific evidence suggests that vitamin D3 supplementation may have significant potential in reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. This report examines the existing research on this relationship, exploring both the neurobiological mechanisms and clinical implications of vitamin D3 as a potential adjunctive therapy for individuals attempting to quit smoking.
!!!! Understanding Nicotine Withdrawal and Its Neurobiological Basis
Nicotine withdrawal represents a significant challenge for individuals attempting to quit smoking, with symptoms typically beginning within 30 minutes of the last cigarette and peaking within the first three to seven days. These symptoms can persist for weeks or even months, significantly increasing the risk of relapse [4] [6]. Common nicotine withdrawal symptoms include intense cravings, anxiety, irritability, depressed mood, difficulty concentrating, insomnia, and restlessness [4] [6]. 
The neurobiological underpinnings of nicotine withdrawal-induced anxiety and depression are complex and involve multiple neurotransmitter systems. One critical mechanism appears to involve the N-Methyl-D-aspartate (NMDA) receptor, a glutamate receptor that plays a significant role in synaptic plasticity, learning, and memory. During nicotine withdrawal, NMDA receptors become overexpressed, particularly the NR2A subunit, which correlates with increased anxiety-like behaviors [1] [2].
!!!!! The NMDA Receptor-Anxiety Connection
Research indicates that NMDA receptor overactivation promotes anxiety and depression through two primary mechanisms:
*1. Decreased protein synthesis through downregulation of the BDNF-PI3K-Akt-mTOR pathway, which impedes maintenance of synapses and growth of new neurons and synapses (processes critical for emotional regulation) [2].
*2. Excessive NMDA activation leading to decreased sensitivity to dopamine in the striatum, a brain region responsible for motivation, reward, and pleasure [2]. This diminished dopaminergic function is associated with both depression and addiction-related withdrawal symptoms.
!!!! Evidence for Vitamin D3&#39;s Effects on Nicotine Withdrawal
!!!!! Animal Studies Demonstrating Efficacy
Recent research has produced compelling evidence that vitamin D3 supplementation may significantly reduce anxiety and depressive-like behaviors induced by nicotine withdrawal. A 2021 study with male C57/BL6 mice demonstrated that dietary supplementation with vitamin D3 (10,000 U/Kg) for six weeks ameliorated anxiety-like behaviors during nicotine withdrawal [1]. Specifically, vitamin D3-treated mice showed:
*1. Increased duration spent in the central zone during open field tests
*2. Decreased numbers of buried marbles in marble-burying tests
*3. Increased exploratory behavior and overall locomotor activity
These behavioral improvements indicate reduced anxiety levels during the nicotine withdrawal period in the supplemented group compared to controls [1].
More recently, a 2025 study with male Wistar rats further confirmed these findings, showing that vitamin D3 administration effectively prevented both anxiety and depression induced by nicotine withdrawal [5]. This study tested various dosages (100, 1000, and 10,000 IU/kg) and found effective results, suggesting a dose-dependent response may exist [5].
!!!! Mechanisms of Vitamin D3&#39;s Anti-Anxiety Effects During Nicotine Withdrawal
!!!!! Modulation of NMDA Receptor Expression
The most well-documented mechanism by which vitamin D3 appears to reduce withdrawal-related anxiety is through downregulation of hippocampal NR2A expression. The 2021 study demonstrated that vitamin D3 supplementation significantly attenuated both protein and mRNA levels of NR2A in the hippocampus of nicotine-withdrawn mice [1]. This suggests that vitamin D3 may directly counteract the pathological overexpression of NMDA receptors that occurs during nicotine withdrawal.
!!!!! Anti-inflammatory Effects
Vitamin D3 also appears to exert anti-inflammatory effects that may contribute to its anti-anxiety properties. Research on methadone maintenance treatment, while not specifically addressing nicotine withdrawal, showed that vitamin D supplementation (50,000 IU every two weeks) downregulated interleukin-1 (IL-1) expression in peripheral blood mononuclear cells [3]. Inflammation has been increasingly linked to both anxiety and depression, suggesting another pathway by which vitamin D3 might improve withdrawal symptoms.
!!!!! Impact on Oxidative Stress and Serotonergic Transmission
The 2025 study further expanded our understanding of vitamin D3&#39;s mechanisms by suggesting its effects may also involve modulation of oxidative stress and serotonergic transmission [5]. While the specifics of these mechanisms require further investigation, this multi-system approach suggests vitamin D3 may address nicotine withdrawal symptoms through several complementary pathways.
!!!! Limitations of Current Evidence and Future Research Directions
While the evidence supporting vitamin D3&#39;s role in reducing nicotine withdrawal-induced anxiety and depression is promising, several important limitations must be acknowledged:
!!!!! Animal vs. Human Studies
The most compelling evidence thus far comes from rodent models, with limited direct evidence in human subjects. The study on methadone maintenance treatment patients found that vitamin D supplementation did not significantly change clinical opiate withdrawal symptoms, suggesting potential differences between opiate and nicotine withdrawal or between animal and human responses [3].
!!!!! Optimal Dosing and Duration (in rats and humans)
Questions remain regarding optimal dosing, timing, and duration of vitamin D3 supplementation for nicotine withdrawal. Studies have used various dosages, from 100 IU/kg to 10,000 IU/kg in animals [1] [5], and 50,000 IU every two weeks in humans [3], without clear consensus on the ideal therapeutic approach.
!!!!! Individual Variability
Baseline vitamin D status likely influences treatment response, but most studies have not stratified results based on pre-existing vitamin D levels. Given the high prevalence of vitamin D deficiency in many populations, including smokers, this represents an important variable for future research.
!!!! Clinical Implications and Practical Applications
Despite these limitations, the existing evidence suggests several potential clinical applications:
!!!!! Adjunctive Therapy for Smoking Cessation
Vitamin D3 supplementation could potentially serve as a safe, accessible adjunctive therapy alongside existing smoking cessation approaches. Given the relatively benign side effect profile of appropriate vitamin D supplementation, it represents a low-risk intervention that might enhance quit rates by reducing withdrawal-related anxiety and depression.
!!!!! Targeted Approach for Vulnerable Populations
The anxiety and depression associated with nicotine withdrawal may be particularly challenging for individuals with pre-existing mental health conditions. For these vulnerable populations, vitamin D3 supplementation might offer specific benefits, though targeted studies are needed.
!!!!! Integration with Existing Approaches
Rather than a standalone treatment, vitamin D3 supplementation could complement existing strategies, including behavioral therapy, nicotine replacement therapy, and other pharmacological interventions. The potential synergistic effects of combining these approaches warrant further investigation.
!!!! Conclusion
The current evidence suggests that vitamin D3 supplementation shows promise for reducing anxiety and depressive-like behaviors associated with nicotine withdrawal. The primary mechanism appears to involve downregulation of NR2A expression in the hippocampus, counteracting the pathological NMDA receptor overactivation that occurs during withdrawal. Additional benefits may stem from vitamin D3&#39;s anti-inflammatory properties and effects on oxidative stress and serotonergic transmission.
While more research is needed, particularly human clinical trials with standardized dosing protocols and attention to baseline vitamin D status, the existing evidence provides a compelling rationale for further investigation of vitamin D3 as a supportive intervention for individuals navigating the challenging process of nicotine withdrawal. For those attempting to quit smoking, especially individuals prone to anxiety or depression, vitamin D3 supplementation may represent a valuable addition to their cessation toolkit.
!!!!!Citations:
 [1] https://pmc.ncbi.nlm.nih.gov/articles/PMC8200643/
 [2] https://www.reddit.com/r/Nootropics/comments/pqpww1/vitamin_d3_reduces_hippocampal_nmdanr2a_and/
 [3] https://brieflands.com/articles/ijpbs-86969
 [4] https://www.verywellmind.com/what-to-expect-from-nicotine-withdrawal-22467
 [5] https://www.tandfonline.com/doi/full/10.1080/13813455.2025.2483508  (Rats: April 2025 $$$ paywall)
 [6] https://www.healthline.com/health/smoking/nicotine-withdrawal
 [7] https://www.sciencedirect.com/science/article/abs/pii/S0006295223004239
 [8] https://www.sciencedirect.com/science/article/pii/S277239252400049X
 [9] https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805442
 [10] https://www.optimallivingdynamics.com/blog/9-nutrients-proven-to-help-you-overcome-addiction-and-withdrawal-nutrition-recovery-vitamins-minerals-amino-acid-symptoms-supplements-diet-substance-drug-abuse-syndrome-cravings-opiate-alcoholism-food
 [11] https://pubmed.ncbi.nlm.nih.gov/40198132/
 [12] https://www.physio-pedia.com/Vitamin_D_and_the_Effect_on_Mental_Health
 [13] https://www.sciencedirect.com/science/article/pii/S2772392525000057
 [14] https://reactionrecovery.com/nicotine/
---
!!!!VitaminDWiki – ((Smoking reduces vitamin D - many studies)) contains:
{include page=&quot;Smoking reduces vitamin D - many studies&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!! {SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 97  OR categId = 48 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL} Interventions for Depression
{category id=&quot;97+48&quot; types=&quot;wiki&quot; sort=&quot;created_desc&quot; split=&quot;n&quot; and=&quot;y&quot; sub=&quot;n&quot; showdescription=&quot;n&quot; showname=&quot;y&quot; showtype=&quot;n&quot; one=&quot;y&quot; showTitle=&quot;n&quot;}  
~tc~ (alias(Stopping smloing increases depression and anxiety, Vitamin D helps (in mice so far)) ~/tc~
~tc~ (alias(Stopping smoking increases depression and anxiety if not increase Vitamin D)) ~/tc~
</code>
</pre>
